metastatic gastric cancer
Showing 1 - 25 of 37
Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)
Recruiting
- Adenocarcinoma
- +8 more
- Radiotherapy targeted to the primary lesion
- +7 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 7, 2023
Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab
Recruiting
- Metastatic Gastric Cancer
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
- Nivolumab Injection
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Aug 23, 2023
Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Amsterdam (89Zr-DFO*-trastuzumab PET scan)
Recruiting
- Breast Cancer
- +5 more
- 89Zr-DFO*-trastuzumab PET scan
-
Amsterdam, Noord-Holland, NetherlandsAmsterdamUMC
Jul 12, 2023
Metastatic Gastric Cancer, PD-L1 Gene Amplification, FGFR2 Amplification Trial in New York (Nivolumab, Capecitabine,
Recruiting
- Metastatic Gastric Cancer
- +2 more
- Nivolumab
- +2 more
-
New York, New YorkBureau for Cancer Research
May 10, 2023
Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Changchun (Trastuzumab for injection, Herceptin)
Completed
- Metastatic Breast Cancer
- Metastatic Gastric Cancer
- Trastuzumab for injection
- Herceptin
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Mar 1, 2023
Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer Trial in Milan (Embolization)
Recruiting
- Hepatocellular Carcinoma
- +6 more
- Embolization
-
Milan, ItalyIRCCS Ospedale San Raffaele
Feb 3, 2023
Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Rotterdam (Tusamitamab ravtansine)
Not yet recruiting
- Metastatic Lung Cancer
- +2 more
- Tusamitamab ravtansine
-
Rotterdam, NetherlandsErasmus MC
Jan 26, 2023
Metastatic Gastric Cancer, Metastatic Breast Cancer, Metastatic Colorectal Cancer Trial in New Taipei City, Taipei
Completed
- Metastatic Gastric Cancer
- +3 more
-
New Taipei City, Taiwan
- +3 more
Sep 21, 2022
Metastatic Gastric Cancer Trial in Zhengzhou (fruquintinib+toripalimab + SOX)
Recruiting
- Metastatic Gastric Cancer
- fruquintinib+toripalimab + SOX
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Aug 17, 2022
Metastatic Gastric Cancer, Metastatic Adenocarcinoma of the Gastroesophageal Junction Trial in Worldwide (Ramucirumab)
No longer available
- Metastatic Gastric Cancer
- Metastatic Adenocarcinoma of the Gastroesophageal Junction
- Ramucirumab
-
Graz, Austria
- +43 more
Aug 17, 2022
Metastatic Gastric Cancer Trial in France (Phycocare, Placebo)
Recruiting
- Metastatic Gastric Cancer
- Phycocare
- Placebo
-
Clermont-Ferrand, France
- +7 more
Jul 8, 2022
Metastatic Gastric Cancer, Surgery, Chemo Trial (Palliative surgery after translational therapy, Chemotheraoy along)
Not yet recruiting
- Metastatic Gastric Cancer
- +2 more
- Palliative surgery after translational therapy
- Chemotheraoy along
- (no location specified)
Mar 30, 2022
Metastatic Cancer, Metastatic Breast Cancer, Metastatic Pancreatic Cancer Trial in Marseille (IPH5301 ALONE OR IN COMBINATION
Recruiting
- Metastatic Cancer
- +8 more
- IPH5301 ALONE OR IN COMBINATION WITH CHEMOTHERAPY AND TRASTUZUMAB
-
Marseille, FranceInstitut Paoli Calmettes
Feb 23, 2022
Metastatic Gastric Cancer Trial in Guangzhou (Irinotecan, Oxaliplatin, 5-fluorouracil)
Recruiting
- Metastatic Gastric Cancer
- Irinotecan
- +2 more
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Jul 13, 2021
Metastatic Esophageal Cancer, Metastatic Gastric Cancer Trial in Sutton (Atezolizumab)
Recruiting
- Metastatic Esophageal Cancer
- Metastatic Gastric Cancer
-
Sutton, Surrey, United KingdomThe Royal Marsden NHS Foundation Trust
Jul 12, 2021
Gastric Adenocarcinoma, Metastatic Gastric Cancer, Metastatic Adenocarcinoma Trial in France (Atezolizumab + Ipatasertib,
Recruiting
- Gastric Adenocarcinoma
- +3 more
- Atezolizumab + Ipatasertib
- Atezolizumab + Bevacizumab
-
Dijon, France
- +8 more
Mar 26, 2021
Metastatic Gastric Cancer Trial in Anyang-si, Hwasun, Seoul (TEW-7197)
Unknown status
- Metastatic Gastric Cancer
-
Anyang-si, Korea, Republic of
- +5 more
Mar 17, 2021
Metastatic Gastric Cancer, Adenocarcinoma of the Gastro-oesophageal Junction Trial in Amsterdam (Docetaxel, Oxaliplatin,
Active, not recruiting
- Metastatic Gastric Cancer
- Adenocarcinoma of the Gastro-oesophageal Junction
- Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab
- Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab, Trastuzumab
-
Amsterdam, NetherlandsNetherlands Cancer Institute
Jan 26, 2021
Metastatic Gastric Cancer Trial in Wuhan (docetaxel)
Unknown status
- Metastatic Gastric Cancer
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Dec 8, 2020
Metastatic Gastric Cancer Trial in Philadelphia (Didactic Session, Comprehensive Geriatric Assessment, including an exploratory
Unknown status
- Metastatic Gastric Cancer
- Didactic Session
- Comprehensive Geriatric Assessment, including an exploratory analysis to evaluate the use of fitness trackers for evaluation of functional status.
-
Philadelphia, Pennsylvania
- +1 more
Nov 9, 2020
Metastatic Gastric Cancer, Locally Advanced Gastric Adenocarcinoma Trial in Shanghai (Camrelizumab plus mFLOT regimen, R0
Unknown status
- Metastatic Gastric Cancer
- Locally Advanced Gastric Adenocarcinoma
- Camrelizumab plus mFLOT regimen
- R0 surgery
-
Shanghai, Shanghai, ChinaFudan University, Shanghai Cancer Center
Aug 11, 2020
Gastroesophageal Junction Adenocarcinoma, Stomach Adenocarcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma Trial in
Unknown status
- Gastroesophageal Junction Adenocarcinoma
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Feb 8, 2020
Metastatic Gastric Cancer Trial in Seoul (durvalumab, tremelimumab, paclitaxel)
Unknown status
- Metastatic Gastric Cancer
- durvalumab, tremelimumab, paclitaxel
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 2, 2019